Description

Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity shares in the ratio of 1:10, effective October 17, 2025, following a stock split from Rs. 10 to Re. 1 face value.

Summary

Welcure Drugs & Pharmaceuticals Limited (Scrip Code: 524661, ISIN: INE331C01025) has completed the allotment of bonus shares in the ratio of 1:10. The company allotted 11,23,58,200 new equity shares of face value Re. 1/- each on October 17, 2025. This bonus issue was preceded by a stock split from Rs. 10 to Re. 1 face value. The paid-up share capital has increased from Rs. 1,12,35,82,000 to Rs. 1,23,59,40,200.

Key Points

  • Company: Welcure Drugs & Pharmaceuticals Limited (CIN: L68100DL1996PLC227773)
  • Scrip Code: 524661
  • ISIN: INE331C01025
  • Bonus Ratio: 1:10 (1 bonus share for every 10 existing shares)
  • Number of Bonus Shares Allotted: 11,23,58,200 equity shares
  • Face Value: Re. 1/- per share (after stock split from Rs. 10)
  • Issue Price: Re. 1/-
  • Distinctive Number Range: 1,12,35,82,001 to 1,23,59,40,200
  • Capital Before Allotment: 1,12,35,82,000 equity shares of Re. 1/- each
  • Capital After Allotment: 1,23,59,40,200 equity shares of Re. 1/- each
  • No Reservation or Abeyance: No bonus shares reserved or kept in abeyance

Regulatory Changes

No regulatory changes introduced by this circular. This is a corporate action disclosure as per listing requirements.

Compliance Requirements

  • The company has submitted revised Annexure I reflecting the stock split effect
  • Initial submission did not account for the share split; corrected from 1,12,35,820 shares to 11,23,58,200 shares
  • Face value updated from Rs. 10.00 to Re. 1.00 in the revised submission

Important Dates

  • Board Approval Date: August 22, 2025
  • Shareholder Approval Date: September 27, 2025
  • Allotment Date: October 17, 2025
  • Effective Listing Date: October 20, 2025

Impact Assessment

Market Impact: The bonus issue increases the number of outstanding shares by 10%, improving liquidity and making shares more affordable to retail investors post the stock split. The combination of stock split (10:1) and bonus issue (1:10) significantly increases the total share count from the original base.

Shareholder Impact: Existing shareholders receive 1 additional share for every 10 shares held. Combined with the stock split, shareholders who originally held 1 share of Rs. 10 face value now hold 11 shares of Re. 1 face value each.

Company Impact: The paid-up capital increases by approximately 10% from Rs. 1,12,35,82,000 to Rs. 1,23,59,40,200. This is a capitalization of reserves with no fresh capital infusion. The action may improve stock liquidity and marketability.

Impact Justification

Corporate action affecting shareholding pattern and share capital structure; medium impact as it's a bonus issue combined with stock split for a single company